Business Description
Embecta Corp
NAICS : 325414
SIC : 3841
ISIN : US29082K1051
Description
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.17 | |||||
| Equity-to-Asset | -0.57 | |||||
| Debt-to-Equity | -2.18 | |||||
| Debt-to-EBITDA | 8.35 | |||||
| Interest Coverage | 1.49 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.45 | |||||
| Beneish M-Score | -1.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2 | |||||
| 3-Year EBITDA Growth Rate | -29.3 | |||||
| 3-Year EPS without NRI Growth Rate | -30.4 | |||||
| 3-Year FCF Growth Rate | -64 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -12.41 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 91.21 | |||||
| 9-Day RSI | 84.13 | |||||
| 14-Day RSI | 78.86 | |||||
| 6-1 Month Momentum % | 6.78 | |||||
| 12-1 Month Momentum % | -23.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.03 | |||||
| Quick Ratio | 1.58 | |||||
| Cash Ratio | 0.72 | |||||
| Days Inventory | 152.74 | |||||
| Days Sales Outstanding | 39.08 | |||||
| Days Payable | 57.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.83 | |||||
| Dividend Payout Ratio | 0.27 | |||||
| Forward Dividend Yield % | 2.95 | |||||
| 5-Year Yield-on-Cost % | 2.83 | |||||
| 3-Year Average Share Buyback Ratio | -0.4 | |||||
| Shareholder Yield % | 3.84 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.46 | |||||
| Operating Margin % | 14.85 | |||||
| Net Margin % | 6.97 | |||||
| FCF Margin % | 1.72 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 6.33 | |||||
| ROIC % | 48.49 | |||||
| ROC (Joel Greenblatt) % | 46 | |||||
| ROCE % | 17.59 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.43 | |||||
| Forward PE Ratio | 6.68 | |||||
| PE Ratio without NRI | 9.43 | |||||
| PS Ratio | 1.08 | |||||
| Price-to-Free-Cash-Flow | 60.91 | |||||
| Price-to-Operating-Cash-Flow | 34.04 | |||||
| EV-to-EBIT | 16.25 | |||||
| EV-to-EBITDA | 13.2 | |||||
| EV-to-Revenue | 2.26 | |||||
| EV-to-FCF | 127.79 | |||||
| Earnings Yield (Greenblatt) % | 6.15 | |||||
| FCF Yield % | 1.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Embecta Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,029.437 | ||
| EPS (TTM) (€) | 1.238 | ||
| Beta | 0 | ||
| Volatility % | 51.43 | ||
| 14-Day RSI | 78.86 | ||
| 14-Day ATR (€) | 0.679191 | ||
| 20-Day SMA (€) | 14.71 | ||
| 12-1 Month Momentum % | -23.17 | ||
| 52-Week Range (€) | 9.35 - 19.4 | ||
| Shares Outstanding (Mil) | 57.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Embecta Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Embecta Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Embecta Corp Frequently Asked Questions
What is Embecta Corp(STU:JX7)'s stock price today?
The current price of STU:JX7 is €19.40. The 52 week high of STU:JX7 is €19.40 and 52 week low is €9.35.
When is next earnings date of Embecta Corp(STU:JX7)?
The next earnings date of Embecta Corp(STU:JX7) is 2025-02-07 Est..
Does Embecta Corp(STU:JX7) pay dividends? If so, how much?
The Dividend Yield %  of Embecta Corp(STU:JX7) is 2.83% (As of Today), Highest Dividend Payout Ratio of Embecta Corp(STU:JX7) was 0.27. The lowest was 0.03. And the median was 0.2. The  Forward Dividend Yield % of Embecta Corp(STU:JX7) is 2.95%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers